Skip to main content
Fig. 2 | Respiratory Research

Fig. 2

From: Prevalence of overuse of short-acting beta-2 agonists (SABA) and associated factors among patients with asthma in Germany

Fig. 2

Number of SABA canisters prescribed to patients with asthma in general and pneumologist practices in Germany. SABA short-acting beta-2 agonist, GP general practitioner. To overcome variability in available SABA canister volumes and maintain consistency with the published threshold of SABA use, use of a canister was defined as 200 puffs by prescription. Consequently, if a patient received only one prescription for a canister containing < 200 puffs, they were classified as receiving < 1 canister

Back to article page